A Targeted Gene Expression Risk Score Predicts Meningioma Outcomes and Responses to Radiotherapy

MLA

D.S. Solomon, et al. “A Targeted Gene Expression Risk Score Predicts Meningioma Outcomes and Responses to Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics, vol. 111, Nov. 2021, pp. S12–13. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2021.07.060.

APA

D.S. Solomon, Michael McDermott, Patricia Sneed, Jenny Kan-Suen Pu, Gilberto K.K. Leung, William C. Chen, Arie Perry, M.S. Berger, Steve Braunstein, Lai-Fung Li, N.A. Oberheim, Minh P. Nguyen, Abrar Choudhury, Tai-Chung Lam, June M. Chan, N. Butowski, Stephen Magill, Jessica Schulte, Harish N. Vasudevan, … Javier Villanueva-Meyer. (2021). A Targeted Gene Expression Risk Score Predicts Meningioma Outcomes and Responses to Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 111, S12–S13. https://doi.org/10.1016/j.ijrobp.2021.07.060

Chicago

D.S. Solomon, Michael McDermott, Patricia Sneed, Jenny Kan-Suen Pu, Gilberto K.K. Leung, William C. Chen, Arie Perry, et al. 2021. “A Targeted Gene Expression Risk Score Predicts Meningioma Outcomes and Responses to Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics 111 (November): S12–13. doi:10.1016/j.ijrobp.2021.07.060.